Please ensure Javascript is enabled for purposes of website accessibility

Is Clorox Stock a Buy?

By Bradley Freeman – Jul 8, 2020 at 8:03AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

How Clorox is navigating through COVID-19.

Few publicly traded companies have done better in the COVID-19 pandemic than Clorox (CLX 0.50%). While some industries faced overwhelming challenges from virus-induced shutdowns, Clorox thrived. Its portfolio of cleaning products was ideal in an environment featuring the public focusing more and more on constant sanitizing and hygiene.

Investors took note of the strong Clorox tailwinds. Not only did Clorox avoid the March stock market crash, the stock price jumped 40% above its previous all-time highs since the shutdowns began. Can this run continue? Let's explore.

Person cleaning flat surface with sponge and rag

Image source: Getty Images.

New Clorox partnerships

The pandemic enabled CEO Benno Dorer to make new revenue-generating partnerships for the company. This year, Clorox announced one such partnership with United Airlines Holdings and the Cleveland Clinic to elevate the cleanliness of planes. The program (called United CleanPlus) aims to limit air travel contact and risk for all passengers and has been very well received by United customers.

Under the auspices of the Cleveland Clinic, Clorox is also working directly with United to make flying safer in every way possible. From self-scanning boarding passes and Clorox's famous disinfecting supplies to sneeze guards for employees, United is all-in on cleaning. Clorox worked directly with a global airline and a world-class hospital to successfully create realistic solutions to COVID-19. It is feasible to think that more announcements like this are coming, but with the stock price already lofty, will new announcements send the stock even higher?

A lofty valuation and fading growth

Following the impressive stock move, Clorox now trades for 32 times mean 2020 earnings estimates (price-to-earnings ratio, or P/E), a sizable premium to the lofty 22.8 P/E the S&P 500 currently fetches. From a sales perspective, Clorox also trades at a valuation premium, trading hands at 4.2 times sales compared to the S&P 500's more modest 1.5 times sales.

Furthermore, Clorox's time in the COVID-19 spotlight may be coming to a close. Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, has repeatedly expressed his expectation of a vaccine by the end of the year. Even if the inoculations take longer, a solution limiting the coronavirus mortality to zero would rapidly ease the public's concern. Humanity's attention span for a crisis is short (think airlines post-2001), especially when the threat no longer exists. In this scenario, it is reasonable to think Clorox's growth will revert to historical norms.

Growth was undeniably impressive during the pandemic, with company sales growing 15% and earnings growing 31%. If Dorer and leadership can maintain this impressive growth, then yes, the valuation premium is deserved. Analysts, however, are not confident it can do so; it looks like Clorox is priced for perfection. Sales from 2020 to 2021 are expected to grow just 1.9%, with earnings set to jump 3.9%. Neither metric screams that Clorox is a growth stock deserving a valuation premium like what it currently enjoys.

While the pandemic juiced growth for Clorox temporarily, there is no guarantee that that boost will persist. Our world will return to normal at some point, and when it does our obsession with cleanliness may wane. For investors who profited handsomely off Clorox's rapid rise, it may be time to take some profits. Investing in short-term trends can end badly, and Clorox's temporary COVID-19 boost already looks to be fading.

Bradley Freeman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Clorox Company Stock Quote
The Clorox Company
CLX
$136.26 (0.50%) $0.68
United Airlines Holdings, Inc. Stock Quote
United Airlines Holdings, Inc.
UAL
$33.92 (3.32%) $1.09
iShares S&P 500 ETF Stock Quote
iShares S&P 500 ETF
IVV
$372.02 (1.94%) $7.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.